SCHEMBL9149805

SCHEMBL9149805

O=C1N=C2C=CC=CN2C(=O)C1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13397617 0.79 ALDH1A1 (0.32)
SCHEMBL7014388 0.79 ALDH1A1 (0.32)
SCHEMBL18663893 0.70
SCHEMBL10134052 0.64 ALDH1A1 (0.31)
SCHEMBL12081656 0.64 ALDH1A1 (0.31)
SCHEMBL2230323 0.63 ALDH1A1 (0.30)
SCHEMBL13310853 0.62
SCHEMBL14139043 0.61 ALDH1A1 (0.32)
SCHEMBL5190873 0.61 ALDH1A1 (0.32)
SCHEMBL5492205 0.58 KDM4E (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5378720-A Treatment of rheumatoid arthritis, emphysema, pancreatitis STERLING WINTHROP INC. (US) 1995-01-03 US disclosed
EP-0626378-A1 Saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1994-11-30 EP disclosed